George Klein

45.0k total citations · 16 hit papers
795 papers, 36.0k citations indexed

About

George Klein is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, George Klein has authored 795 papers receiving a total of 36.0k indexed citations (citations by other indexed papers that have themselves been cited), including 427 papers in Oncology, 248 papers in Immunology and 221 papers in Molecular Biology. Recurrent topics in George Klein's work include Viral-associated cancers and disorders (345 papers), Lymphoma Diagnosis and Treatment (177 papers) and Parvovirus B19 Infection Studies (140 papers). George Klein is often cited by papers focused on Viral-associated cancers and disorders (345 papers), Lymphoma Diagnosis and Treatment (177 papers) and Parvovirus B19 Infection Studies (140 papers). George Klein collaborates with scholars based in Sweden, United States and United Kingdom. George Klein's co-authors include Eva Klein, Beverley M. Reedman, Werner Henle, Mikael Jondal, Kenneth Nilsson, Gertrude Henle, Ingemar Ernberg, László Székely, Maria G. Masucci and János Luka and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

George Klein

786 papers receiving 32.9k citations

Hit Papers

Cellular localization of an Epstein‐Barr virus (EBV)‐asso... 1960 2026 1982 2004 1973 1976 1995 1960 1981 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines
    1973 1.5k citations George Klein et al. profile →
  2. Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas
    1976 661 citations L. Zech, George Klein et al. profile →
  3. Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1
    1995 634 citations Stefan Imreh, George Klein et al. profile →
  4. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
    1960 565 citations George Klein, Hans Olof Sjögren et al. PubMed profile →
  5. The role of gene dosage and genetic transpositions in carcinogenesis
    1981 549 citations George Klein profile →
  6. Evolution of tumours and the impact of molecular oncology
    1985 539 citations George Klein, Eva Klein profile →
  7. Suppression of Malignancy by Cell Fusion
    1969 440 citations George Klein et al. profile →
  8. SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES
    1973 428 citations Mikael Jondal, George Klein The Journal of Experimental Medicine profile →
  9. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men
    1983 426 citations George Klein profile →
  10. An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection
    1975 397 citations George Klein et al. Intervirology profile →
  11. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
    1975 362 citations J Menezes, Wolfgang Leibold et al. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) profile →
  12. Antibodies to Epstein-Barr Virus in Burkitt's Lymphoma and Control Groups<xref ref-type="fn" rid="FN2">2</xref>
    1969 347 citations Gertrude Henle, Werner Henle et al. profile →
  13. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate
    1979 336 citations János Luka, George Klein et al. profile →
  14. Continuous Lymphoid Cell Lines with Characteristics of B Cells (Bone-Marrow-Derived), Lacking the Epstein-Barr Virus Genome and Derived from Three Human Lymphomas
    1974 288 citations George Klein, Mikael Jondal et al. profile →
  15. Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the Nasopharynx
    1974 261 citations George Klein et al. profile →
  16. Relationship between Epstein‐Barr virus (EBV) DNA and the EBV‐determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies
    1974 204 citations George Klein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Klein Sweden 91 20.0k 10.6k 10.0k 8.3k 7.0k 795 36.0k
Elliott Kieff United States 99 22.8k 1.1× 9.0k 0.8× 5.7k 0.6× 11.1k 1.3× 9.6k 1.4× 281 31.9k
Alan B. Rickinson United Kingdom 95 23.4k 1.2× 12.6k 1.2× 3.2k 0.3× 10.8k 1.3× 9.7k 1.4× 285 31.7k
Stuart A. Aaronson United States 107 12.2k 0.6× 6.4k 0.6× 27.9k 2.8× 2.0k 0.2× 3.4k 0.5× 438 45.8k
Arlene H. Sharpe United States 130 28.8k 1.4× 47.7k 4.5× 16.3k 1.6× 2.4k 0.3× 5.9k 0.8× 408 75.8k
Mark Raffeld United States 90 14.1k 0.7× 7.8k 0.7× 6.6k 0.7× 11.0k 1.3× 2.2k 0.3× 428 27.4k
Gordon J. Freeman United States 141 38.6k 1.9× 54.1k 5.1× 14.7k 1.5× 5.5k 0.7× 6.8k 1.0× 419 82.7k
J. Michael Bishop United States 116 9.5k 0.5× 5.7k 0.5× 33.0k 3.3× 1.9k 0.2× 4.1k 0.6× 356 48.6k
Alain Fischer France 111 7.4k 0.4× 25.9k 2.4× 14.3k 1.4× 1.5k 0.2× 7.0k 1.0× 706 46.7k
Michel C. Nussenzweig United States 136 7.7k 0.4× 39.4k 3.7× 20.1k 2.0× 2.0k 0.2× 5.0k 0.7× 379 61.3k
Lieping Chen United States 112 34.3k 1.7× 36.0k 3.4× 9.2k 0.9× 2.3k 0.3× 3.4k 0.5× 368 55.6k

Countries citing papers authored by George Klein

Since Specialization
Citations

This map shows the geographic impact of George Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Klein more than expected).

Fields of papers citing papers by George Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Klein. The network helps show where George Klein may publish in the future.

Co-authorship network of co-authors of George Klein

This figure shows the co-authorship network connecting the top 25 collaborators of George Klein. A scholar is included among the top collaborators of George Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Klein. George Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heuts, Frank, Martı́n E. Rottenberg, Dániel Salamon, et al.. (2014). T Cells Modulate Epstein-Barr Virus Latency Phenotypes during Infection of Humanized Mice. Journal of Virology. 88(6). 3235–3245. 29 indexed citations
2.
Klein, George. (2014). Evolutionary aspects of cancer resistance. Seminars in Cancer Biology. 25. 10–14. 29 indexed citations
3.
Levan, Göran, Nils Mandahl, U Bregula, George Klein, & ALBERT LEVAN. (2009). Double minute chromosomes are not centromeric regions of the host chromosomes. Hereditas. 83(1). 83–90. 11 indexed citations
4.
Klein, George. (2009). Burkitt lymphoma—A stalking horse for cancer research?. Seminars in Cancer Biology. 19(6). 347–350. 18 indexed citations
5.
Zhang, Sizhong, et al.. (2008). Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. Hereditas. 97(1). 23–28. 11 indexed citations
6.
Radek, Renate, George Klein, & Völker Storch. (2002). The spore of the unicellular organism Nephridiophaga blattellae: ultrastructure and substances of the spore wall. Acta Protozoologica. 41(2). 7 indexed citations
7.
Szeles, Anna, et al.. (2000). Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.. PubMed. 60(24). 7119–25. 12 indexed citations
8.
Talmadge, Catherine B., DongKai Zhen, Jiyi Wang, et al.. (1995). Construction and Characterization of a NotI Linking Library from Human Chromosome Region 1q25-qter. Genomics. 29(1). 105–114. 3 indexed citations
9.
Axelson, Håkan, et al.. (1995). The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas. European Journal of Cancer. 31(12). 2099–2104. 13 indexed citations
10.
Kuraya, Mikio, George Klein, Eva Klein, & Eitan Yefenof. (1992). Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum‐mediated lysis. European Journal of Immunology. 22(7). 1871–1876. 33 indexed citations
11.
Åman, Pierre, Barbro Ehlin‐Henriksson, & George Klein. (1984). Epstein-Barr virus susceptibility of normal human B lymphocyte populations.. The Journal of Experimental Medicine. 159(1). 208–220. 160 indexed citations
12.
13.
Berkel, A.I. van, Werner Henle, Gertrude Henle, et al.. (1981). Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia.. BMJ. 282(6262). 425–427. 79 indexed citations
14.
Saemundsen, Ari K., David T. Purtilo, Kiyoshi Sakamoto, et al.. (1981). Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.. PubMed. 41(11 Pt 1). 4237–42. 111 indexed citations
15.
Kärre, Klas, et al.. (1980). THE GENETIC REGULATION OF NK‐ACTIVITY: STUDIES ON CONGENIC MICE WITH B10 OR AKR BACKGROUND. International Journal of Immunogenetics. 7(5). 401–407. 4 indexed citations
16.
Svedmyr, Erik, Mikael Jondal, Werner Henle, et al.. (1978). EBV specific killer T cells and serologic responses after onset of infectious mononucleosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(3). 225–32. 11 indexed citations
17.
McConnell, I., P. J. Lachmann, Thomas F. Lint, & George Klein. (1978). The Capacity of Lymphoblastoid Cells to Activate the Alternative Complement Pathway Is Correlated with their Transformation by Epstein-Barr Virus. The Journal of Immunology. 120(5). 1787–1787. 1 indexed citations
18.
Fenyö, E M, Eitan Yefenof, E. Klein, & George Klein. (1977). Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens.. The Journal of Experimental Medicine. 146(6). 1521–1533. 25 indexed citations
19.
Menezes, J, Wolfgang Leibold, George Klein, & G Clements. (1975). Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(4). 276–84. 362 indexed citations breakdown →
20.
Sjögren, Hans Olof, Ingegerd Hellström, & George Klein. (1961). Transplantation of Polyoma Virus-induced Tumors in Mice. Cancer Research. 21(3). 329–337. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elliott Kieff Breakdown of academic impact, for papers by Alan B. Rickinson Breakdown of academic impact, for papers by Stuart A. Aaronson Breakdown of academic impact, for papers by Arlene H. Sharpe Breakdown of academic impact, for papers by Mark Raffeld Breakdown of academic impact, for papers by Gordon J. Freeman Breakdown of academic impact, for papers by J. Michael Bishop Breakdown of academic impact, for papers by Alain Fischer Breakdown of academic impact, for papers by Michel C. Nussenzweig Breakdown of academic impact, for papers by Lieping Chen
Rankless by CCL
2026